Target intelligence / Profile preview

Major fimbrial subunit FanC (FanC)

Target
FanC
Molecular classification
Bacterial adhesin, Fimbrial protein, Pilin, Surface antigen
01

Overview

The Escherichia coli K99 pilus FanC subunit is the major structural protein of the F5 (K99) fimbriae, which are essential virulence factors in enterotoxigenic E. coli (ETEC) (UniProt P18103). These pili facilitate the attachment of the bacteria to the small intestinal epithelium of neonatal calves, lambs, and piglets by binding to specific glycolipid receptors, such as N-glycolylneuraminic acid-containing GM3 gangliosides (QED Bioscience). This adhesion is a critical first step in the pathogenesis of neonatal diarrhea, allowing the bacteria to colonize the gut and release enterotoxins (NIH, PMC4048151). Because FanC is the primary component of the pilus filament, it is a major target for immunological interventions (NIH, PMC5791551). Therapeutic strategies primarily focus on preventing colonization through the use of maternal vaccines that induce protective antibodies in colostrum or the administration of oral monoclonal antibodies to newborns (Merck Animal Health). By blocking the FanC-mediated attachment, these treatments effectively prevent the onset of severe dehydration and mortality associated with ETEC infections in livestock (PubMed, 3919874).

Other names
K99 fimbrial proteinF5 fimbrial subunitFanC proteinK99 major pilinK99 surface antigen
02

Mechanism of action

Antibodies bind to the FanC subunit, sterically hindering the interaction between the K99 pilus and host intestinal glycolipid receptors (Neu5Gc-GM3), thereby preventing bacterial colonization.

03

Biological functions

Bacterial adhesionIntestinal colonizationHost-pathogen interactionReceptor binding
04

Disease associations

Neonatal diarrhea (scours)Enterotoxigenic Escherichia coli (ETEC) infectionColibacillosis
05

Safety considerations

Injection site reactionsAnaphylaxisPassive immunity failure due to inadequate colostrum intake
06

Interacting drugs

ScourGuard 4K

4 more in the full profile.

07

Biomarkers

K99 fimbrial antigen (ELISA)fanC gene (PCR)K99-specific colostral antibody titers

Beyond the preview

Go deeper on Major fimbrial subunit FanC (FanC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Major fimbrial subunit FanC (FanC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call